Schedule 13D ownership disclosure
TURNING POINT THERAPEUTICS I
Security class unavailable · CUSIP: 90041T108
Event date: 2020-05-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-20-000510
- Form type
- SC 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- May 22, 2020
- Reporting period
- May 21, 2020
- Description
- Schedule 13D beneficial ownership